Welspun Corp Limited has announced its participation in four investor conferences scheduled across August and September 2026. The disclosure, filed on August 7, 2026, outlines the specific dates and venues where company representatives will engage with investors, ensuring transparency regarding upcoming market interactions.

The intimation was issued pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during any of the scheduled meetings, maintaining compliance with regulatory standards for information dissemination.

Conference Schedule

Representatives from Welspun Corp will participate in the following investor groups:

The company noted that the schedule of these meetings may undergo changes due to exigencies on the part of the host or the company. Investors are advised to monitor official communications for any potential updates to these dates.

Regulatory Compliance

The filing was signed by Kamal Rathi, Company Secretary and Compliance Officer of Welspun Corp Limited. The disclosure covers equity shares listed on BSE Limited (Scrip Code: 532144) and NSE Limited (Symbol: WELCORP, Series EQ), as well as Non-Convertible Debentures (NCDs) listed on BSE (Scrip Code: 973309). The ISIN for the equity shares is INE191B01025.

This routine disclosure ensures that all stakeholders are aware of the company’s planned engagements with the investment community, facilitating orderly market conduct and preventing information asymmetry.

Welspun Corp Limited has published the full transcript of its first-quarter fiscal year 2027 (Q1 FY27) earnings call, providing investors with a detailed written record of management’s commentary on financial performance. The transcript, corresponding to the earnings call held on July 27, 2026, was filed with stock exchanges on July 30, 2026. This disclosure ensures that all stakeholders have equal access to the nuances of the management discussion, complementing the previously released audio recording.

The filing was submitted by Kamal Rathi, Company Secretary of Welspun Corp Limited, to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Ltd (NSE). The communication cites compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory step is designed to maintain market transparency by making the textual record of the investor interaction publicly available.

Accessing the Transcript

Investors can access the Q1 FY27 earnings call transcript via the company’s official website at www.welspuncorp.com . The document is hosted under the Investors section, specifically within the Financials Results tab for Financial Year 2026-2027, under the Q1 category. A direct PDF link is provided in the exchange filing to facilitate easy retrieval for stakeholders seeking detailed insights into the quarter’s operational updates.

Regulatory Compliance

The release of the earnings call transcript is a mandatory disclosure under SEBI Listing Regulations. By publishing the text, Welspun Corp Limited fulfills its obligation to disseminate information that may impact investment decisions in a permanent and searchable format. The filing references specific scrip codes for equity (532144) and NCDs (973309) on BSE, and the symbol WELCORP on NSE, ensuring clarity for traders across both exchanges.

What the Numbers Show

While this filing primarily serves as a procedural notification regarding the availability of the earnings call transcript, it underscores the company’s adherence to governance standards. The absence of specific financial metrics in this particular document means that investors must refer to the earlier quarterly results announcement or the transcript itself for detailed figures on revenue, net profit, or EBITDA. The focus here remains on the mechanism of disclosure rather than the financial outcomes themselves.